Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.4.2181

Review of Selenium and Prostate Cancer Prevention  

Yang, Lei (Department of Urology, The First Affiliated Hospital of Chongqing Medical University)
Pascal, Mouracade (Department of Urology, Nouvel Hopital Civil, Universite de Strasbourg)
Wu, Xiao-Hou (Department of Urology, The First Affiliated Hospital of Chongqing Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.4, 2013 , pp. 2181-2184 More about this Journal
Abstract
Prostate cancer is the most common malignancy in men in the United States. Surgery or radiation are sometimes unsatisfactory treatments because of the complications such as incontinence or erectile dysfunction. Selenium was found to be effective to preven prostate cancer in the Nutritional Prevention of Cancer Trial (NPC), which motivated two other clinical trials: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) and a Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia. However, these two trials failed to confirm the results of the NPC trial and indicated that the selenium may not be preventive of prostate cancer. In this article we review the three clinical trials and discuss some different points which might be potential factors underlying variation in results obtained.
Keywords
Selenium; prostate cancer; prevention; clinical trials;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sabichi AL, Lee JJ, Taylor RJ, et al (2006). Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group study. Clin Cancer Res, 12, 2178-84.   DOI   ScienceOn
2 Sanda MG, Dunn RL, Michalski J, et al (2008). Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med, 358, 1250-61.   DOI   ScienceOn
3 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.   DOI   ScienceOn
4 Silberstein JL, Parsons JK (2010). Prostate cancer prevention: concepts and clinical recommendations. Prostate Cancer Prostatic Dis, 13, 300-6.   DOI   ScienceOn
5 Ware JH, Zhou Z, Kopelovich L, et al (2006). Evaluation of cancer chemopreventive agents using clones derived from a human prostate cancer cell line. Anticancer Res, 26, 4177-83.
6 Zhang J, Wang L, Li G, et al (2011). Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutr Cancer, 63, 778-89.   DOI   ScienceOn
7 Zhang Y, Skolarus TA, Miller DC, et al (2011). Understanding prostate cancer spending growth among medicare beneficiaries. Urology, 77, 326-31.   DOI   ScienceOn
8 Clark LC, Combs GF, Turnbull BW, et al (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-63   DOI   ScienceOn
9 Clark LC, Dalkin B, Krongrad A, et al (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81, 730-4.   DOI   ScienceOn
10 Diwadkar-Navsariwala V, Prins GS, Swanson SM, et al (2006). Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A, 103, 8179-84.   DOI   ScienceOn
11 Hu JC, Gu X, Lipsitz SR, et al (2009). Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA, 302, 1557-64.   DOI   ScienceOn
12 Duffield-Lillico AJ, Dalkin BL, Reid ME, et al (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int, 91, 608-12.   DOI   ScienceOn
13 Grundmark B, Zethelius B, Garmo H, et al (2011). Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer, 11, 431.   DOI
14 Hsing AW, Chokkalingam AP(2006). Prostate cancer epidemiology. Front Biosci, 11, 1388-413.   DOI   ScienceOn
15 Hurst R, Hooper L, Norat T, et al (2012). Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr, 96, 111-22.   DOI   ScienceOn
16 Lippman SM, Goodman PJ, Klein EA, et al (2005). Designing the selenium and vitamin E cancer prevention trial (SELECT). J Natl Cancer Inst, 97, 94-102.   DOI   ScienceOn
17 Lippman SM, Klein EA, Goodman PJ, et al (2009). Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA, 301, 39-51.   DOI   ScienceOn
18 Marshall JR, Tangen CM, Sakr WA, et al (2011). Phase III trial of selenium to prevent [rostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila), 4, 1761-9.   DOI   ScienceOn
19 Ozten N, Horton L, Lasano S, et al (2010). Selenomethionine and-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model. Cancer Prev Res (Phila), 3, 371-80.   DOI   ScienceOn
20 Rayman MP(2000). The importance of selenium to human health. Lancet, 356, 233-41.   DOI   ScienceOn